News + Announcements
Recent Research News
Timely treatment of lesions that may cause anal cancer can cut risk, mortality by 80 percent, UF study shows
No guidelines exist for the treatment of precancerous anal lesions that might ultimately develop into anal cancer, leaving physicians to make a best guess about whether to remove them or wait and watch to see if they go away on their own. A study led by a UF researcher offers recommendations for treating the lesions in a high-risk group that could lower patients’ risk of developing anal cancer by 80 percent. READ MORE
UF researchers hope clinical trial will lead to new sepsis treatment
University of Florida researchers are part of a nationwide clinical trial to evaluate whether an anti-cancer medication can be effective against sepsis and septic shock. The clinical trial seeks to determine whether blocking PD-1 can also boost the immune system in patients with severe sepsis or septic shock. UF is the only center in Florida, and one of four in the Southeast, recruiting participants. READ MORE
Common, edible mushroom has potential to kill one type of leukemia cell, UF Health researchers find
An edible, shaggy-looking mushroom contains a protein that is a potent killer of a certain leukemia cell, a group of University of Florida researchers has found. The Coprinus comatus mushroom, commonly known as the lawyer’s wig or shaggy mane, killed human T-cell leukemia cells during laboratory tests, the researchers found. Its potency and ability to selectively target leukemia cells makes it a promising candidate for cancer treatment, researchers said. READ MORE
Immunotherapy treatment shows effectiveness against deadly brain tumor during early tests
Glioblastoma is an aggressive, stubborn brain tumor with low odds of survival for patients. Now, University of Florida Health researchers have found a way to target a molecule that lets the tumor grow, migrate and evade the body’s immune system. The molecule, known as CD70, is found on the surface of glioblastoma tumors. READ MORE
UF researchers identify gene variant to personalize therapy for deadly form of leukemia
A genetic variation identified by researchers at UF Health may help clinicians target a deadly form of leukemia using a promising drug therapy. In a study published in the Journal of Clinical Oncology, UF Health researchers in the UF College of Pharmacy found that genetic variation within patients with CD33 — a surface molecule that acts as a receptor for drug therapy on a leukemia cell — can predict the effectiveness of the anti-leukemic drug gemtuzumab ozogamicin, or GO. READ MORE
Brain cancer trial first clinical research collaboration of UF Health and Orlando Health joint program
A new phase II clinical trial currently enrolling patients with glioblastoma is the first clinical research collaboration of University of Florida Health’s joint oncology program with Orlando Health. The study builds on prior UF research, including a small, randomized phase I trial led by Duane A. Mitchell, M.D., Ph.D., the Phyllis Kottler Friedman professor in the Lillian S. Wells department of neurosurgery, that resulted in several patients with the disease living longer than average — and, in a few cases, markedly delayed tumor progression. READ MORE
UF Health researchers identify novel genetic links between herpes virus and cancer
A dormant herpes virus uses its proteins and small RNAs to create genetic changes that can cause cancer in patients with AIDS and other immune deficiencies, a team of University of Florida Health researchers has found. The virus, known as Kaposi’s sarcoma-associated herpesvirus, is the agent that that causes Kaposi’s sarcoma and blood cancers. READ MORE
Follow Us on Social Media
Have you heard? The UF Health Cancer Center is on Facebook, and we recently launched a Twitter account. If you use social media — either personally or in professionally — please consider following one or both accounts! These platforms reach both internal and external audiences and are a great way to stay up-to-date with events and research news. If you have something to share on our Facebook or Twitter pages, please send to firstname.lastname@example.org.
Get Your Flu Shot!
All UF Health Science Center college physicians, residents and clinical providers; UF Health Shands employees; UF Health Physicians employees; credentialed ARNPs, physician assistants and medical staff; students; trainees; vendors; and volunteers who provide service in UF Health Shands; UF College of Medicine and UF Health Physicians; UF College of Dentistry; UF College of Health and Health Professions; UF College of Pharmacy and UF College of Nursing facilities and programs must either receive a flu vaccination or opt out of the vaccination by Oct. 30, 2017. All others are encouraged to get vaccinated this fall to help us keep ourselves, our colleagues and our community safe this flu season. See the full schedule here: https://bridge.ufhealth.org/flu/
New Brand Commercials
If you have not had the chance, please visit ProblemSolvingCare.org and watch the new UF Health commercials featuring Dr. Lisa Spiguel and Dr. William Slayton. This spot, and the other commercials are running on television throughout the state of Florida. Also running are print ads, digital ads, outdoor and radio. The site also features a story from patient Debby Paine, an interview with Dr. Spiguel, and a segment featuring Dr. Spiguel meeting the child actress who played her in the commercial. It similarly features a story from patient Tionna Moore, an interview with Dr. Slayton and a segment where Dr. Slayton meets the child actor who plays him. We are hugely excited that breast cancer and pediatric cancer featured so prominently in UF Health’s newest campaign.
Need to Update Your Professional Portrait?
UF Health Creative Services offers open studio hours at Communicore C2-20 every month. Simply stop by during one of the time slots listed on the bottom of their webpage — there’s no need to sign up beforehand, and it only takes five minutes! Here are some of the upcoming sessions:
- 10/30 3p-4p
- 11/01 9a-10a
- 11/14 9a-10a
- 11/16 3p-4p
- 11/27 3p-4p
- 11/29 9a-10a